Volume 23, Issue 2 (8-2009)                   Med J Islam Repub Iran 2009 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Javidi D, Saffarian N. Nonconventional therapeutic modalities in refractory angina pectoris. Med J Islam Repub Iran 2009; 23 (2) :96-104
URL: http://mjiri.iums.ac.ir/article-1-80-en.html
Pars Hospital. , research_cardio@yahoo.com
Abstract:   (6292 Views)

 

  Abstract

  Despite sophisticated conventional medical treatment and the continued development

  and improvement of coronary revascularization modalities in recent years, a significant

  number of patients still suffer from refractory angina pectoris and cannot be successfully

  managed. Advances in therapeutic options have led to an increase in the average of life

  expectancy even in such no-option patients. Management of these patients is a challenging problem because most of them have already undergone multiple coronary interventions or surgeries and therefore are not suitable candidates for further procedures. In this situation, cardiologists who frequently face the patients are limited in their decision making when all therapeutic methods have been exhausted. The aim of this review article was to draw attention to the novel therapeutic strategies currently available for this condition, including nonconventional medical treatment, improving myocardial perfusion, neuromodulation, new vessel formation and eventually heart transplantation. Unfortunately, these therapies have only a complementary role because of inadequate experience. Therefore, maximal conventional treatment along with these options should be used on an individual basis.

 

Full-Text [PDF 74 kb]   (2054 Downloads)    
Type of Study: Review Article | Subject: Cardiovascular Surgery

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.